---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-113833"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-08T23:32:06.598877+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Select Medical Q3 revenue $1.67B (+6.2%), EPS $0.38 (+75.8%), maintains FY outlook

## Summary
- Q3 revenue $1,665.7M (+6.2% YoY); net income $60.8M (+59.5%).
- Q3 adjusted EBITDA $193.8M (+26.6%); adjusted EPS $0.46 (+113.7%).
- Critical illness recovery hospital segment Adjusted EBITDA surged 321% to $46.4M.
- FY 2023 outlook maintained: revenue $6.55B-$6.7B, Adj. EBITDA $795M-$825M, EPS $1.77-$1.94.
- Board declared $0.125/share dividend payable Nov 28; $1.0B stock repurchase program authorized.

## SEC filing metadata
- accession: 0001104659-23-113833
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465923113833/0001104659-23-113833-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465923113833/tm2329685d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-113833
- JSON: https://secwatch.observer/filing/0001104659-23-113833.json
- Plain text: https://secwatch.observer/filing/0001104659-23-113833.txt

## Key facts
- Earnings Releases
  SELECT MEDICAL HOLDINGS CORP reported third quarter ended September 30, 2023 results: revenue $1,665.7 million, net income $60.8 million, EPS $0.38.
  - Period: third quarter ended September 30, 2023
  - Revenue: $1,665.7 million
  - Net income: $60.8 million
  - EPS: $0.38
  - Result: reported results
  source text: For the third quarter ended September 30, 2023, revenue increased 6.2% to $1,665.7 million, compared to $1,567.8 million for the same quarter, prior year. Income from operations increased 42.1% to $130.0 million for the third quarter ended September 30, 2023, compared to $91.5 million for the same quarter, prior year. For the third quarter ended September 30, 2023, income from operations included $0.5 million of other operating income, compared to $8.4 million of other operating income for the same quarter, prior year. The other operating income for the third quarter ended September 30, 2022, was principally related to the recognition of payments received under the Coronavirus Aid, Relief, and Economic Security Act Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund. Net income increased 59.5% to $60.8 million for the third quarter ended September 30, 2023, compared to $38.1 million for the same quarter, prior year. Adjusted EBITDA increased 2
  evidence_url: https://www.sec.gov/Archives/edgar/data/1320414/000110465923113833/0001104659-23-113833-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.